Eli Lilly (LLY) Total Liabilities (2016 - 2025)
Historic Total Liabilities for Eli Lilly (LLY) over the last 17 years, with Q4 2025 value amounting to $85.9 billion.
- Eli Lilly's Total Liabilities rose 3335.97% to $85.9 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $85.9 billion, marking a year-over-year increase of 3335.97%. This contributed to the annual value of $85.9 billion for FY2025, which is 3335.97% up from last year.
- As of Q4 2025, Eli Lilly's Total Liabilities stood at $85.9 billion, which was up 3335.97% from $91.1 billion recorded in Q3 2025.
- In the past 5 years, Eli Lilly's Total Liabilities registered a high of $91.1 billion during Q3 2025, and its lowest value of $37.3 billion during Q3 2022.
- Over the past 5 years, Eli Lilly's median Total Liabilities value was $45.1 billion (recorded in 2023), while the average stood at $53.3 billion.
- In the last 5 years, Eli Lilly's Total Liabilities plummeted by 730.07% in 2022 and then soared by 4862.17% in 2025.
- Over the past 5 years, Eli Lilly's Total Liabilities (Quarter) stood at $39.7 billion in 2021, then dropped by 2.36% to $38.7 billion in 2022, then skyrocketed by 37.27% to $53.1 billion in 2023, then rose by 21.26% to $64.4 billion in 2024, then soared by 33.36% to $85.9 billion in 2025.
- Its Total Liabilities was $85.9 billion in Q4 2025, compared to $91.1 billion in Q3 2025 and $82.6 billion in Q2 2025.